Navigation Links
Collagen Meniscus Implant

ProductsCollagen Meniscus Implant
Company ReGen Biologics
Item Collagen Meniscus Implant
Features 
  • A type I collagen implant designed for patients with an irreparable meniscus tear or loss of meniscus tissue
  • The purpose of the CMI is to assist patients to regain mobility and return to a more vigorous lifestyle, while forestalling or minimizing degenerative joint disease.
  • Assists the body to generate new tissue, which replaces the damaged meniscus tissue removed by the surgeon.
  • The result is designed to provide patients with increased mobility and a return to a more active lifestyle.
  • Description The Collagen Meniscus Implant (CMI) is a type I collagen implant designed for patients with an irreparable meniscus tear or loss of meniscus tissue, typically through an arthroscopic partial meniscectomy procedure. The purpose of the CMI is to assist patients to regain mobility and return to a more vigorous lifestyle, while forestalling or minimizing degenerative joint disease. The Collagen Meniscus Implant is a method of regenerating meniscus tissue using the body's own healing process. A next generation approach to tissue repair, the CMI assists the body to generate new tissue, which replaces the damaged meniscus tissue removed by the surgeon. The result is designed to provide patients with increased mobility and a return to a more active lifestyle. The CMI is a resorbable type I collagen scaffold designed to minimize progressive degenerative changes in the knee after a partial meniscectomy by providing an alternative to the permanent loss of meniscus tissue. The CMI is similar to the natural shape of the meniscus and it is made of highly purified collagen, the most commonly found protein in the body. In cases where meniscus tissue cannot be repaired by suturing, the damaged tissue is removed and the CMI is sutured in place filling the defect where tissue is missing. Once sutured in place, the CMI provides a matrix into which the body's own cells may begin to move or migrate. New meniscus tissue is formed as these cells migrate and multiply. As this tissue regeneration takes place, the CMI is absorbed by the body. The regenerated tissue has the potential to restore function, reduce pain, and possibily suspend the degenerative process that begins with the loss of meniscus tissue. The CMI is made of type I collagen and it is a biocompatible, bioresorbable material that is designed to provide a scaffold for tissue growth when implanted in the knee. The surgeon sutures the CMI into the area where the meniscus tissue is missing. Once implanted, the CMI's highly porous matrix allows cellular ingrowth from the patient's own cells. This process regenerates meniscus tissue which provides the potential for restoring function, reducing pain and possibly arresting the degenerative process that begins with the loss of meniscus tissue.
    Info ReGen Biologics
    Customer Service: (201) 651-5140
    Web site: http://www.regenbio.com

    Related medicine products :

    1. Temporary Collagen Plugs
    2. Ultrafoam Collagen Sponge
    3. UltraPlug Collagen Absorbably Punctal Plugs
    4. INSTAT Collagen Absorbable Hemostat
    5. Pelvicol Acellular Collagen Matrix (Continence)
    6. Contigen Bard Collagen Implant
    7. Pelvicol® Acellular Collagen Matrix
    8. PelviSoft® Acellular Collagen BioMesh
    9. Hydrix XM Collagen Matrix
    10. Zyderm® and Zyplast® Injectable Collagen Implants
    11. CosmoDerm®and CosmoPlast® Collagen Replacement Therapy®
    Inquire...
    ... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
    ... with concave seats and standard-sized backrests ... like seats, backrests, armrests, and casters ... recommended for the following environments: industry, ... health care and office. • With ...
    ... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTN/1Q-CAB chairs are recommended for ... clean room, static control, health care ...
    Medicine Products:
    (Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
    (Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
    (Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
    (Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
    (Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
    Breaking Medicine News(10 mins):
    (Date:6/26/2016)... of Australia,s successful biotechnology scientists, Dr ... company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is ... the ASX. Noxopharm is a clinic-ready company with its ... clinical study later this year. ... facing cancer patients - the ability of cancers to become resistant ...
    (Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
    (Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
    Breaking Medicine Technology: